The tools could be used by primary care providers to head off adverse respiratory events and suboptimal healthcare utilization. 

An AI application that interprets MRI scans of the brain for signs or confirmation of injury has received 510(k) clearance from the FDA.

The FDA has cleared UK-based Ultromics to sell an AI-powered tool for diagnosing coronary artery disease (CAD) on echocardiograms.

The FDA has OK’d AI software that can predict worsening condition in ICU patients up to eight hours before the falloff produces symptoms.

AI has proven capable of automatically detecting looming heart trouble on CT scans taken for lung issues like lung cancer, pulmonary embolism and pneumonia.

Researchers have used deep learning software to accurately detect age-related cognitive impairment using only photos of patients’ faces.

The idea is to head off serious gathering threats without getting thrown off the scent by strains unlikely to proliferate.

AI melanoma detectors that equaled or bettered dermatologists in clinical trials have stumbled on the way to the real world of patient care. 

One turnoff is remote food monitoring. Another is real-time feedback—whether from a live healthcare professional or an AI algorithm.

Researchers have found that some AI models do better, on average, than expert psychiatrists at the difficult task.